SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 5/08/19 Dyadic International Inc 8-K:1,8,9 5/07/19 3:169K |
Document/Exhibit Description Pages Size 1: 8-K 8-K Serum HTML 20K 2: EX-10.1 Material Contract HTML 31K 3: EX-99.1 Miscellaneous Exhibit HTML 18K
Document |
Delaware (State
or other jurisdiction of incorporation or organization) | (Commission File Number) | 45-0486747 (I.R.S. Employer Identification Number) |
140 Intracoastal Pointe Drive, Suite 400 | ||
(Address
of principal executive offices and zip code) | ||
(561) 743-8333 | ||
(Registrant's telephone number, including area code) | ||
N/A (Former Name or Former Address, if Changed Since Last Report) |
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.001 per share | DYAI | The NASDAQ Stock Market LLC |
Exhibit Number | Exhibit
Description | |
10.1 | Research and Commercialization Collaboration Agreement with Serum Institute of India Pvt,. Ltd., dated May 7, 2019. Specific items in this exhibit have been redacted, as marked by three asterisks [***]. | |
99.1 |
Dyadic
International, Inc. | ||
Date: May 8, 2019 | By: | /s/ Mark A. Emalfarb |
Name: | ||
Title: | Chief
Executive Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/8/19 | 8-K | ||
For Period End: | 5/7/19 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Dyadic International Inc. 10-K 12/31/23 64:6.6M RDG Filings/FA 3/29/23 Dyadic International Inc. 10-K 12/31/22 58:5.9M RDG Filings/FA 3/29/22 Dyadic International Inc. 10-K 12/31/21 58:5.9M RDG Filings/FA 7/27/21 Dyadic International Inc. 10-K/A 12/31/20 16:370K RDG Filings/FA 3/30/21 Dyadic International Inc. 10-K 12/31/20 57:5.8M RDG Filings/FA |